Mark Tepper, Ph.D. in

Mark Tepper, Ph.D.

Login to view DISC.
Board Chair at Eumentis Therapeutics Inc.
📍 Greater Boston, United States

Mark Tepper is a serial biotech entrepreneur with a Ph. D. from Columbia University. He has a proven track record of founding innovative companies like Eumentis, Corbus, and Primatope, leading them from inception to successful exits. His expertise spans drug discovery and development across oncology, immunology, and neurodegenerative diseases.

After a distinguished 30-year career, Mark is now semi-retired and open to part-time board or advisory roles. He has several personal hobbies including SCUBA diving, fishing, boating, marine aquaria, beer making, and gardening. His entrepreneurial ventures even extended to aquaculture, having founded a company for shellfish production.

Unique fact: Beyond his extensive biopharma career, he founded and later sold Atlantic Aquaculture Technologies, a company that developed specialized vessels for producing oysters and clams.

Read the full overview →
Experience
13 Years
Current Role
Board Chair
Location
Greater Boston, United States
Personality Overview

How Mark shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Mark cares about

Biotech Entrepreneurship
A serial founder with a track record of building and exiting multiple therapeutic companies, including Eumentis, Primatope (sold to Kiniksa), and Corbus Pharmaceuticals.
Neuroscience Therapeutics
As Founder of Eumentis Therapeutics, he is actively developing novel drugs for neurodevelopmental and neurodegenerative disorders like Alzheimer's, Autism, and Schizophrenia.
+5 more topics Login to view topics
Career

Work history

1-2025
Board Chair
Eumentis Therapeutics Inc.
8-2019 - 6-2025
Founder, President & CEO
Eumentis Therapeutics Inc.
5-2019 - 11-2024
Founder and Investor
Atlantic Aquaculture Technologies
4-2012 - 6-2019
Founder, CEO and Board Member
Primatope Therapeutics, Inc.
3-2019
Founder, President and CSO
Corbus Pharmaceuticals
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
9-1980 - 1-1985
Ph.D.
Columbia University Vagelos College of Physicians and Surgeons
4-1985 - 4-1988
Postdoctoral Fellow
UMass Chan Medical School
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Mark. Free, 10 seconds.